MarketInOut Stock Screener Log In | Sign Up

Wanbury Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:50
Wanbury Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization6,224.11 mln
Float17.31 mln

EPS

16.28
Robust

P / E

10.87
Fair value

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-1.62
Likely manipulated

Relative Strength

30 / 100
Underperforming

Debt / Equity

1.57
High leverage

Business Description

Founded in 1988 and based in Navi Mumbai, India, Wanbury Limited is a pharmaceutical company that produces and sells medicines and active drug ingredients both within India and abroad. Its finished medicines cover a broad range of health conditions, including infections, pain, digestive disorders, respiratory issues, and mental health. The company also supplies raw drug ingredients used by other manufacturers to produce treatments for diabetes, depression, allergies, inflammation, and several other conditions.

Key Fundamentals

EPS16.28
P/E10.87
ROE53.92
RPS200
ROIC25.18
ROA12.08
Interest Cover2.76
EBITDA, mln959
EV / EBITDA10.20
EV / EBIT12.05
Revenue, mln6,527
EV / Revenue1.50

Quote Details

Last 177.00
Change 10 (5.99%)
Open 164.15
Volume 8,297
Turnover 1,468,569
Average Volume 22,917

Financial Ratios

Pre-Tax Profit Margin8
Current Ratio1.19
Price / Book4.81
Price / Tangible Book4.90
Debt / Equity1.57
Price / Sales1.04
PEG Ratio0.54

Financial Strength

Altman Z-Score2.97
Piotroski F-Score 6 / 9
Beneish M-Score-1.62
Price to Lynch Fair Value0.71
Price to Graham Number1.47
Shiller PE Ratio14.38

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -4.43% 43 / 100   
1 Month -22.23% 6 / 100   
2 Months -48.28% 1 / 100   
6 Months -32.7% 11 / 100   
1 Year -24.36% 41 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog